Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 14

1.

Experimental approaches for the treatment of malignant gliomas.

Arko L, Katsyv I, Park GE, Luan WP, Park JK.

Pharmacol Ther. 2010 Oct;128(1):1-36. doi: 10.1016/j.pharmthera.2010.04.015. Epub 2010 Jun 8. Review.

2.

Health care reform and the need for comparative-effectiveness research.

Mushlin AI, Ghomrawi H.

N Engl J Med. 2010 Jan 21;362(3):e6. doi: 10.1056/NEJMp0912651. Epub 2010 Jan 6. No abstract available.

3.

Bevacizumab alone and in combination with irinotecan in recurrent glioblastoma.

Friedman HS, Prados MD, Wen PY, Mikkelsen T, Schiff D, Abrey LE, Yung WK, Paleologos N, Nicholas MK, Jensen R, Vredenburgh J, Huang J, Zheng M, Cloughesy T.

J Clin Oncol. 2009 Oct 1;27(28):4733-40. doi: 10.1200/JCO.2008.19.8721. Epub 2009 Aug 31.

PMID:
19720927
4.

Phase II trial of single-agent bevacizumab followed by bevacizumab plus irinotecan at tumor progression in recurrent glioblastoma.

Kreisl TN, Kim L, Moore K, Duic P, Royce C, Stroud I, Garren N, Mackey M, Butman JA, Camphausen K, Park J, Albert PS, Fine HA.

J Clin Oncol. 2009 Feb 10;27(5):740-5. doi: 10.1200/JCO.2008.16.3055. Epub 2008 Dec 29.

5.

Preoperative prognostic classification system for hemispheric low-grade gliomas in adults.

Chang EF, Smith JS, Chang SM, Lamborn KR, Prados MD, Butowski N, Barbaro NM, Parsa AT, Berger MS, McDermott MM.

J Neurosurg. 2008 Nov;109(5):817-24. doi: 10.3171/JNS/2008/109/11/0817.

PMID:
18976070
6.

Malignant gliomas in adults.

Wen PY, Kesari S.

N Engl J Med. 2008 Jul 31;359(5):492-507. doi: 10.1056/NEJMra0708126. Review. No abstract available. Erratum in: N Engl J Med. 2008 Aug 21;359(8):877.

PMID:
18669428
7.

The 2007 WHO classification of tumours of the central nervous system.

Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, Jouvet A, Scheithauer BW, Kleihues P.

Acta Neuropathol. 2007 Aug;114(2):97-109. Epub 2007 Jul 6. Review. Erratum in: Acta Neuropathol. 2007 Nov;114(5):547.

9.

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma.

Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, Belanger K, Brandes AA, Marosi C, Bogdahn U, Curschmann J, Janzer RC, Ludwin SK, Gorlia T, Allgeier A, Lacombe D, Cairncross JG, Eisenhauer E, Mirimanoff RO; European Organisation for Research and Treatment of Cancer Brain Tumor and Radiotherapy Groups; National Cancer Institute of Canada Clinical Trials Group.

N Engl J Med. 2005 Mar 10;352(10):987-96.

10.

Survival and functional status after resection of recurrent glioblastoma multiforme.

Barker FG 2nd, Chang SM, Gutin PH, Malec MK, McDermott MW, Prados MD, Wilson CB.

Neurosurgery. 1998 Apr;42(4):709-20; discussion 720-3.

PMID:
9574634
11.

The value of reoperation for recurrent glioblastoma.

Dirks P, Bernstein M, Muller PJ, Tucker WS.

Can J Surg. 1993 Jun;36(3):271-5.

PMID:
8391917
12.

Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery.

Walker MD, Green SB, Byar DP, Alexander E Jr, Batzdorf U, Brooks WH, Hunt WE, MacCarty CS, Mahaley MS Jr, Mealey J Jr, Owens G, Ransohoff J 2nd, Robertson JT, Shapiro WR, Smith KR Jr, Wilson CB, Strike TA.

N Engl J Med. 1980 Dec 4;303(23):1323-9.

PMID:
7001230
13.

Reoperation for recurrent glioblastoma and anaplastic astrocytoma.

Harsh GR 4th, Levin VA, Gutin PH, Seager M, Silver P, Wilson CB.

Neurosurgery. 1987 Nov;21(5):615-21.

PMID:
2827052
14.

Reoperation in the treatment of recurrent intracranial malignant gliomas.

Ammirati M, Galicich JH, Arbit E, Liao Y.

Neurosurgery. 1987 Nov;21(5):607-14.

PMID:
2827051

Supplemental Content

Support Center